The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use.
Saved in:
| Title: | The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use. |
|---|---|
| Authors: | Yamaoka K; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan., Kajita S; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan., Kume M; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan., Hirabatake M; Department of Pharmacy, Kobe City Medical Center West Hospital, Kobe, Japan., Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan., Hashida T; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan., Tachikawa R; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan., Muroi N; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 11; Vol. 17, pp. 1712949. Date of Electronic Publication: 2026 May 11 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1712949 |
